In House Methodology to Assign the Mechanism of Action of New Annelated Triazolopyrimidine Derivatives with Anticancer Activity

Research output: Contribution to conferenceOther

Original languageUndefined/Unknown
Pages108-108
Publication statusPublished - 2005

Cite this